Skip to content
Screener

Indivior Pharmaceuticals, Inc. INDV EBITDA

EBITDA at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$68.46M-25.4%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-$4.09M+78.7%
Alkermes logo
AlkermesALKS
$48.63M-51.8%
TRV
Trevi Therapeutics, Inc.TRVI
-$14.88M-30.1%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
-$101.1M-503%

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.58B+64.7%
Enterprise value$4.92B+86.4%
P/E18.3×-7.5×
P/S3.6×+1.2×

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%—

Returns & leverage

See full
Return on equity-117%—
Debt / equity-3.5×—
Current ratio0.9×0.0×

Where this comes from

Calculated from Indivior Pharmaceuticals, Inc.’s reported figures.

$137.0Mebit+
$2.0MDepreciation Depletion & Amortization
=$139M

The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026. Open the filing →

Filed
Apr 30, 2026, 4:02 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028850

FAQ

What is Indivior Pharmaceuticals, Inc.'s EBITDA?
Indivior Pharmaceuticals, Inc. (INDV) reported EBITDA of $139M in Q1 2026.
How has Indivior Pharmaceuticals, Inc.'s EBITDA changed year-over-year?
Indivior Pharmaceuticals, Inc.'s EBITDA increased by 101.4% year-over-year, from $69M to $139M.
What is the long-term trend for Indivior Pharmaceuticals, Inc.'s EBITDA?
Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s EBITDA has grown at a 64.6% compound annual growth rate (CAGR), from -$61M to $272M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Indivior Pharmaceuticals, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude